or Try an Advanced Search...

    Blood Cancers Stocks List

    Symbol Grade Name % Change
    ADPT C Adaptive Biotechnologies Corporation -0.11
    PYXS C Pyxis Oncology, Inc. -44.63
    ESLA D Estrella Immunopharma, Inc. -2.23
    ABBV F AbbVie Inc. 2.52
    KURA F Kura Oncology, Inc. -34.19
    BPTH F Bio-Path Holdings Inc 5.50
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Shell Companies
    Related Stock Lists: Cancer Solid Tumors Biotechnology Leukemia Lymphoma Medicine Oncogenes Acid Acute Leukemia Acute Myeloid Leukemia Adalimumab Advanced Prostate Cancer Anemia Antibody Drug Conjugate Antineoplastic Drugs Apoptosis Atopic Dermatitis Autoimmune Disease Benzamides Blood Test

    Related ETFs - A few ETFs which own one or more of the above listed Blood Cancers stocks.

    Symbol Grade Name Weight
    HDLB B ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 9.8
    BOTZ B Global X Robotics & Artificial Intelligence Thematic ETF 9.31
    MEDX F Horizon Kinetics Medical ETF 7.81
    GRID D First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund 7.75
    FDL A First Trust Morningstar ETF 6.79
    View all Blood Cancers ETFs...
    Compare ETFs
    Compare BOTZ to FDL Compare BOTZ to MEDX Compare GRID to FDL

        Blood Cancers Stocks Recent News

        Date Stock Title
        Nov 21 KURA Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results
        Nov 21 PYXS Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results
        Nov 21 PYXS Pyxis stock craters 46% amid Phase 1 data, William Blair downgrade
        Nov 21 KURA Kura Oncology Slams The Door On Its Takeover Narrative, And Shares Collapse 26%
        Nov 21 KURA Kura Oncology partners Kyowa Kirin to advance AML treatment
        Nov 20 KURA Kura stock slides 17% on Kyowa Kirin deal for ziftomenib
        Nov 20 PYXS Pyxis Oncology plummets 38% on preliminary phase 1 data for cancer asset
        Nov 20 KURA Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias
        Nov 20 PYXS Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data
        Nov 20 ABBV Unpacking the Latest Options Trading Trends in AbbVie
        Nov 19 ABBV Where Will AbbVie Be in 5 Years?
        Nov 19 ABBV ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap
        Nov 19 ABBV RVPH: Year-End OLE Update
        Nov 19 ABBV What is a ‘cure,’ really? AbbVie’s Humira creator leaps into the next phase of medicine
        Nov 18 ABBV AbbVie snaps eight straight sessions of losses
        Nov 18 ABBV Aldeyra announces FDA acceptance of resubmitted reproxalap application
        Nov 18 ABBV AbbVie's Ovarian Cancer Drug Elahere Gets Approval in Europe
        Nov 18 ABBV Allergan Aesthetics Offers Free Business Education Courses Online to Support Growing Practices with Allergan Aesthetics Products
        Nov 18 ABBV AbbVie’s Elahere wins European approval for certain ovarian cancers
        Nov 18 ABBV Why This Beaten-Down Dividend Stock Is a No-Brainer Buy on the Dip
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Shell Companies
        Related Stock Lists: Cancer Solid Tumors Biotechnology Leukemia Lymphoma Medicine Oncogenes Acid Acute Leukemia Acute Myeloid Leukemia Adalimumab Advanced Prostate Cancer Anemia Antibody Drug Conjugate Antineoplastic Drugs Apoptosis Atopic Dermatitis Autoimmune Disease Benzamides Blood Test
        Blood Cancers

        Blood cancer is a type of cancer that affects the cells of the blood, bone marrow, and lymphatic system. It is also known as hematological cancer. Blood cancers can include leukemia, lymphoma, and myeloma. Symptoms of blood cancer can include fatigue, fever, weight loss, and swollen lymph nodes. Treatment for blood cancer may include chemotherapy, radiation, and stem cell transplant.

        Browse All Tags